In January 2016, Russ joined the Health Care Investment Banking group of Stifel, Inc. as a Vice Chairman and Managing Director. He has been a Senior Advisor to HLM Venture Partners since January 2014 and was a Partner from September 2003 to December 2013. Russ is currently a Director of Merrimack Pharmaceuticals, Inc. and was a Director of Allergan, Inc. from 2003 to 2015. Russ previously was a Director or Board observer of Cbr Systems, Infomedics and Phreesia, Inc. Prior to joining HLM in 2003, Russ was a Managing Director and Global Co-Head of Health Care Investment Banking at Credit Suisse First Boston where he focused on providing strategic and financial advice to life sciences, health care services and medical device companies.
Prior to joining Credit Suisse First Boston in 1999, Russ spent twelve years at Deutsche Bank and its predecessor entities, BT Alex. Brown and Alex. Brown & Sons, as a Managing Director and Global Head of Health Care Investment Banking. Russ began his investment banking career in 1982 as a member of the High Technology and Emerging Growth Group at Merrill Lynch. During his investment banking career, Russ completed over 175 merger and financing transactions for leading health care companies in the United States, Europe and Israel.
Russ received a BS from the United States Military Academy, a BS from the University of Washington, a MS from the University of Pennsylvania and an MBA from the Wharton School.